)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Talis Biomedical
Talis Biomedical (TLIS) investor relations material
Talis Biomedical has been otc
Talis Biomedical Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2024 earnings summary18 Aug, 2024
Executive summary
Ceased all research and development and revenue-generating activities as of June 30, 2024, after failing to identify viable strategic alternatives; company expects to file for Chapter 11 bankruptcy and liquidate assets.
Implemented a 90% workforce reduction in November 2023 and consolidated operations to Chicago, IL.
Board established a Special Restructuring Committee to oversee bankruptcy and asset liquidation.
Financial highlights
Net loss of $8.8 million for Q2 2024, compared to $15.0 million in Q2 2023; net loss of $21.9 million for the six months ended June 30, 2024, down from $32.9 million year-over-year.
Total revenue for Q2 2024 was $0.05 million, down from $0.58 million in Q2 2023; six-month revenue was $0.07 million, down from $1.8 million year-over-year.
Research and development expenses fell to $1.6 million in Q2 2024 from $10.6 million in Q2 2023; selling, general and administrative expenses rose to $8.0 million from $6.4 million.
Cash and cash equivalents were $59.9 million as of June 30, 2024.
Outlook and guidance
Unrestricted cash and cash equivalents expected to fund operations for at least 12 months from the financial statement issuance date.
No plans to commercialize the Talis One system; all R&D and revenue activities suspended.
Anticipates commencing voluntary Chapter 11 proceedings to resolve claims and liquidate assets.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Talis Biomedical
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Talis Biomedical Corp is a molecular diagnostic company focused on health and patient outcomes through the development and delivery of accurate infectious disease testing at the point of care. The company's efforts are concentrated on diagnosing infectious diseases rapidly, accurately, and directly at the point-of-care. Their product development includes the Talis One system, designed to overcome the limitations of existing point-of-care diagnostic testing technologies, with applications in respiratory infections, women's health infections, sexually transmitted infections, and more. The company is headquartered in Redwood City, California and its shares are listed on the Nasdaq.